Literature DB >> 932427

Chemotactic responses of normal human basophils to C5a and to lymphocyte-derived chemotactic factor.

M A Lett-Brown, D A Boetcher, E J Leonard.   

Abstract

Peripheral blood basophils from normal human subjects responded chemotactically to the complement component C5a and also to the supernatant fluid from cultured human lymphocytes stimulated by mitogens or specific antigen. Basophil chemotactic factor (BCF) was detected in stimulated lymphocyte cultures within 24 hr and increased for the first 3 days. BCF was found after stimulation of lymphocytes by B or T cell mitogens as well as by specific antigen. The amount of BCF in culture fluids was independent of cell proliferation. Monocyte chemotactic factor (MCF) and BCF could not be separated from one another by Sephadex or DEAE chromatography. Both activities were eluted from Sephadex G-100 columns in a m.w. region of about 15,000 daltons and were found after ion exchange chromatography on DEAE in a peak eluted by 0.1 M NaCl. These findings suggest that mitogen or antigen-stimulated lymphocytes secrete a molecule that is chemotactic for both monocytes and basophils. Thus, in the absence of a basophil-specific chemotactic molecule, the preferential accumulation of basophils in certain types of delayed hypersensitivity skin reactions must be due to additional factors such as basophil chemotaxis augmentation factor.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 932427

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  The pathology of atopic dermatitis.

Authors:  A K Tong; M C Mihm
Journal:  Clin Rev Allergy       Date:  1986-02

2.  Serum basophil-stimulating activity in the guinea-pig during induction of basophilic responses to ovalbumin and tick feeding.

Authors:  J A Denburg; P W Askenase; S J Brown; J Bienenstock
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

3.  Enhancement of basophil chemotaxis in vitro by virus-induced interferon.

Authors:  M A Lett-Brown; M Aelvoet; J J Hooks; J A Georgiades; D O Thueson; J A Grant
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

4.  Prolonged reduction in basophil counts at cutaneous basophil hypersensitivity reaction sites challenged with antigen.

Authors:  M Desaules; P W Askenase
Journal:  Immunology       Date:  1982-06       Impact factor: 7.397

Review 5.  The role of lymphokines in delayed-type hypersensitivity reactions.

Authors:  C L Geczy
Journal:  Springer Semin Immunopathol       Date:  1984

Review 6.  Structure and function of the anaphylatoxins.

Authors:  T E Hugli
Journal:  Springer Semin Immunopathol       Date:  1984

Review 7.  Basophils in human disease.

Authors:  E B Mitchell; P W Askenase
Journal:  Clin Rev Allergy       Date:  1983-09

8.  Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage.

Authors:  M Fung; M Lu; H Fure; W Sun; C Sun; N Y Shi; Y Dou; J Su; X Swanson; T E Mollnes
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

9.  Adherence of human basophils to cultured umbilical vein endothelial cells.

Authors:  B S Bochner; P T Peachell; K E Brown; R P Schleimer
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

10.  Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils.

Authors:  R Alam; M A Lett-Brown; P A Forsythe; D J Anderson-Walters; C Kenamore; C Kormos; J A Grant
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.